During intervention , the clonidine group had a lower number of steps per day ( mean difference , -637 steps ; P = .07 ) , lower plasma norepinephrine level ( mean difference , -42 pg/mL ; P = .01 ) , and lower serum C-reactive protein concentration ( mean ratio , 0.69 ; P = .02 ) compared with the CFS placebo group .